camptothecin has been researched along with pevonedistat in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, B; Deng, H; Gu, S; Li, Y; Lin, C; Shen, Z; Wei, Z | 1 |
1 other study(ies) available for camptothecin and pevonedistat
| Article | Year |
|---|---|
Neddylation inhibitor MLN4924 sensitizes head and neck squamous carcinoma cells to (S)-10-hydroxycamptothecin.
Topics: Camptothecin; Head and Neck Neoplasms; Humans; Squamous Cell Carcinoma of Head and Neck | 2023 |